Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.76% | $2.85B | €347.07B | 30.57% | 76 Outperform | |
| AstraZeneca | 1.20% | $1.94B | £209.38B | 28.56% | 80 Outperform | |
| Roche Holding AG | 1.20% | $1.94B | CHF256.01B | 38.07% | 73 Outperform | |
| HSBC Holdings | 1.09% | $1.76B | HK$1.99T | 46.73% | 80 Outperform | |
| Novartis AG | 1.09% | $1.76B | CHF204.56B | 21.14% | 80 Outperform | |
| SAP SE | 1.07% | $1.74B | €241.18B | -14.07% | 66 Neutral | |
| Nestlé SA | 1.07% | $1.74B | CHF198.25B | 17.61% | 71 Outperform | |
| Siemens | 0.90% | $1.45B | €186.01B | 23.12% | 74 Outperform | |
| Shell (UK) | 0.86% | $1.40B | £149.91B | 8.82% | 73 Outperform | |
| Toyota Motor | 0.86% | $1.39B | ¥43.40T | 25.16% | 80 Outperform |